209 related articles for article (PubMed ID: 15811577)
1. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
He Q; Riley RT; Sharma RP
Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
[TBL] [Abstract][Full Text] [Related]
2. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases.
He Q; Kim J; Sharma RP
Toxicol Sci; 2004 Aug; 80(2):335-42. PubMed ID: 15103051
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): a model for reducing fumonisin-induced nephrotoxicity in vivo.
He Q; Riley RT; Sharma RP
Pharmacol Toxicol; 2002 May; 90(5):268-77. PubMed ID: 12076308
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells.
Rentz SS; Showker JL; Meredith FI; Riley RT
Food Chem Toxicol; 2005 Jan; 43(1):123-31. PubMed ID: 15582204
[TBL] [Abstract][Full Text] [Related]
5. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.
Enongene EN; Sharma RP; Bhandari N; Miller JD; Meredith FI; Voss KA; Riley RT
Toxicol Sci; 2002 Jun; 67(2):173-81. PubMed ID: 12011476
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of serine palmitoyltransferase by myriocin, a natural mycotoxin, causes induction of c-myc in mouse liver.
He Q; Johnson VJ; Osuchowski MF; Sharma RP
Mycopathologia; 2004 Apr; 157(3):339-47. PubMed ID: 15180163
[TBL] [Abstract][Full Text] [Related]
7. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
Merrill AH; van Echten G; Wang E; Sandhoff K
J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
[TBL] [Abstract][Full Text] [Related]
8. Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine.
Sharma RP; He Q; Riley RT
Toxicology; 2005 Dec; 216(1):59-71. PubMed ID: 16159691
[TBL] [Abstract][Full Text] [Related]
9. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
10. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
He Q; Riley RT; Sharma RP
Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
[TBL] [Abstract][Full Text] [Related]
11. Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride.
He Q; Kim J; Sharma RP
Toxicology; 2005 Feb; 207(1):137-47. PubMed ID: 15590129
[TBL] [Abstract][Full Text] [Related]
12. S-adenosylmethionine or 5'-methylthioadenosine are unable to prevent fumonisin B1 hepatotoxicity in mice despite increased oxidation in liver.
He Q; Suzuki H; Sharma RP
J Appl Toxicol; 2006; 26(6):509-16. PubMed ID: 17080400
[TBL] [Abstract][Full Text] [Related]
13. Selective and transient activation of protein kinase C alpha by fumonisin B1, a ceramide synthase inhibitor mycotoxin, in cultured porcine renal cells.
Gopee NV; Sharma RP
Life Sci; 2004 Feb; 74(12):1541-59. PubMed ID: 14729403
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor necrosis factor alpha signaling by anti-tumor necrosis factor alpha antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice.
He Q; Sharma RP
Toxicon; 2005 Sep; 46(4):404-13. PubMed ID: 16054185
[TBL] [Abstract][Full Text] [Related]
15. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity.
Gopee NV; Sharma RP
Toxicology; 2003 May; 187(2-3):239-50. PubMed ID: 12699912
[TBL] [Abstract][Full Text] [Related]
16. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
Tsunoda M; Sharma RP; Riley RT
J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.
Suzuki H; Riley RT; Sharma RP
Toxicology; 2007 Jan; 229(1-2):42-53. PubMed ID: 17095132
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin exposure alters brain and liver effects of fumonisin B1 in BALB/c mice: implication of blood brain barrier.
Osuchowski MF; He Q; Sharma RP
Food Chem Toxicol; 2005 Sep; 43(9):1389-97. PubMed ID: 15913876
[TBL] [Abstract][Full Text] [Related]
19. Deletion of IFN-gamma reduces fumonisin-induced hepatotoxicity in mice via alterations in inflammatory cytokines and apoptotic factors.
Sharma RP; He Q; Johnson VJ
J Interferon Cytokine Res; 2003 Jan; 23(1):13-23. PubMed ID: 12639295
[TBL] [Abstract][Full Text] [Related]
20. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
Yoo HS; Norred WP; Showker J; Riley RT
Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
